ArticleCEN case reports2026
Repeat kidney biopsy reveals new-onset IgA nephropathy in a patient with ANCA-associated vasculitis.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microscopic polyangiitis (MPA) is a subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Although relapse during maintenance therapy is relatively common, the coexistence or subsequent development of other glomerular diseases, such as IgA nephropathy, is rare. We report the case of an 81-year-old woman diagnosed with renal-limited AAV nine years earlier. Initial presentation was characterized by elevated myeloperoxidase (MPO)-ANCA levels and crescentic glomerulonephritis. Remission was achieved with prednisolone, and her serum creatinine level remained stable at approximately 0.9 mg/dL with low-dose maintenance therapy. Over the course of follow-up, she experienced two episodes of MPO-ANCA elevation accompanied by microscopic hematuria, both of which responded to an increased dose of prednisolone. At the current presentation, the MPO-ANCA level had been gradually increasing, and she developed proteinuria (3.44 g/gCr), microscopic hematuria (20-29/high-power field), and an elevated serum creatinine level (1.28 mg/dL), suggestive of a relapse of AAV presenting as rapidly progressive glomerulonephritis. However, a repeat kidney biopsy revealed new-onset IgA nephropathy. This case highlights the new-onset development of IgA nephropathy during long-term maintenance therapy for MPA. It underscores the importance of considering alternative glomerular pathologies and performing repeat kidney biopsy in patients with established AAV who present with clinical deterioration. Given the rarity of coexisting AAV and IgA nephropathy, further case accumulation and investigation are warranted to better understand their potential association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.